RO7197597, TAMOXIFEN clinical trials

PREOPERATIVE WINDOW OF OPPORTUNITY STUDY WITH GIREDESTRANT (GDC-9545) OR TAMOXIFEN IN PREMENOPAUSAL WOMEN WITH ER[+]/HER2[-] & KI67≥10% EARLY BREAST CANCER

This study looks at new ways to treat early breast cancer in women before menopause. It compares a new medicine, giredeastrant, with a common treatment, tamoxifen, to see how they affect cancer cell growth before surgery. It aims to find the best treatment options.